The plastic emergency

Plastics are essential materials in our lives, but they show a problem: they are difficult to degrade. As a consequence, 79% of the plastic waste is stored in landfills or released into the environment.

Taking advantage of microbes

Some bacteria can degrade common plastics such as polyethylene (PET) or polyurethane (PU) by secreting enzymes. In addition, certain species can be modified to use these materials as food to obtain energy.

A circular solution

MIPLACE will develop a process that uses plastic waste as a feedstock for engineered microbial communities. These microbes will transform it into the raw materials used to create a sustainable plastic, Bio-PU, that can enter the cycle once thrown away.

LATEST NEWS

New article on the enzymatic degradation of PET

15/11/22 - Our partners from the University of Leipzig and their colleagues from the Helmholtz Centre Dresden-Rossendorf have recently published an article on the enzymatic degradation of PET.  The article, [...]

MIPLACE represented at Synthetic Biology UK 2022

07/11/22 - MIPLACE partner, Dr Alice Banks, gave a fascinating talk today on microbial degradation and upcycling of polyethylene terephthalate (PET) to value-added products at the Synthetic Biology UK 2022 [...]

New publications on enzymatic plastic degradation

18/10/22 - Our partners from the University of Leipzig have recently published articles on enzymatic plastic degradation. The article 'PET recycling - with enzymes against the plastic crisis' by Dr [...]

Good microbes and bio-based plastics

10/10/22 - Our partners from RWTH Aachen University and their colleagues have contributed to a new publication, 'Good Microbes in Medicine, Food Production, Biotechnology, Bioremediation and Agriculture'.  A link to [...]

Talking with Open Age

30/09/22 - MIPLACE partners, Jose Jimenez, Alice Banks and Joanne Benton from Imperial College London, recently gave a talk on the work of MIPLACE and plastic-related matters to members of [...]

See more

PARTNERS

MIPLACE project is funded under the 2nd ERA BioTech Joint Transnational Call